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placenta and fetal membranes is not known.
We examined whether amnion and placental tissue obtained between 12 and 15 weeks of gestation produced CRH in vitro, whether steroid modulation of output occurred and whether CRH affected prostaglandin (PG) (hCRH) mRNA has been detected in the human placenta from 7 to 40 weeks of gestation, and increases more than 20-fold during the last 5 weeks of gestation ). The increase in placental hCRH mRNA coincides with the increase in hCRH peptide content in placental tissue . These Saijonmaa, Laatikainen & Wahlstrom, 1988) .
Corticotrophin-releasing hormone is produced not only by the placenta, but also by the fetal membranes and decidua during late gestation (Saijonmaa et al. 1988; Jones, . Output of hCRH in monolayer tissue culture is modulated by steroids ). In particular, glucocorticoids stimulate and progesterone inhibits hCRH output . It has been suggested that in vivo these steroids may be synthesized locally within the intra-uterine tissues . In addition, hCRH stimulates, in a dose-dependent manner, secretion from the placenta of a peptide containing the adrenocorticotrophic hormone (ACTH) sequence (Petraglia, Sawchenko, Rivier & Vale, 1987) . Thus Radioimmunoassay of CRH Concentrations of ir-CRH were determined by radioimmunoassay (Brooks, Power, Jones et al. 1989) in media from amnion and placental cultures. The standard curve was prepared in tubes containing 0-3 ml culture medium taken from wells that had been coated with Vitrogen but were without cells. For the series of studies described, the inter-and intra-assay coefficients of variation were <10 and 15% respect¬ ively, and the minimum detectable dose ranged between 3-2 and 5-5 pmol/tube. Ll.
ä. (Margioris, Grino, Protos et al. 1988) during the termination of pregnancy may be possible factors which increase the output of CRH from the intra-uterine tissues.
Modulation of amnion and placental ir-CRH by steroids Output of ir-CRH by both amnion and placental cells was modulated by steroids. We found that glucocorti¬ coids had both stimulatory and inhibitory effects on ir-CRH production by amnion cells in vitro. The output of ir-CRH by amnion tissue following glucocorticoid treatment was greater in early than in late gestation ). The output of ir-CRH by placental cells was increased by cortisol. In the presence of dexamethasone, however, ir-CRH output initially increased, but then decreased at the higher concentration of 26 nmol/1.
Extrapolating between the in-vivo and the in-vitro situation, the concentration of steroids and peptides used in this study are within the physiological range for the steroid concentrations found in amniotic fluid (Jonasson & Johansson, 1971; Murphy, Patrick & Dentón, 1975) , and placental CRH (Sasaki et al. 1987) and ACTH (Odagiri, Sherrell, Mount et al. 1979) content. Amniotic fluid concentrations of corti¬ sol during the first 15 weeks of gestation are in the range of 13-5-27 nmol/1, and increase to approxi¬ mately 54 nmol/1 during the second half of gestation (Murphy et al. 1975 ). This cortisol is derived, in part, from the fetus, and also as a result of the increasing ability of the amnion to convert cortisone to cortisol (Tanswell, Worthington & Smith, 1977) . Changes in the sensitivity of the amnion to increasing levels of cortisol during pregnancy may influence placental production of hCRH and prostaglandins. The differ¬ ent responses of the amnion and placenta to cortisol may be due to differences in glucocorticoid receptor affinity of each tissue. Lopez-Bernal & Turnbull (1985) .
In late pregnancy, PGE2 is the major PG produced by the amnion (Casey, MacDonald & Mitchell, 1984 (Okita, Johnston & MacDonald, 1983) . The difference in production of prostaglandins by amnion between early and late pregnancy may be also due to higher PG 9-ketoreductase or lower PGE2 isomerase activity in early pregnancy.
It has been found that PGE2 promoted collagen synthesis in cervical tissue from early trimester preg¬ nancies, but decreased proline incorporation into collagen later in gestation and at term (Ekaman et al. 1986 ). Since prostaglandins are involved in the physiological activation of myometrial activity, it is not easy to separate the actions of the prostaglandins on the uterus, fetal membranes and cervix. In early pregnancy when plasma and placenta CRH concen¬ trations are low (Sasaki et al. 1984; Goland et 
